YARNO WENDY L 4
4 · Tarsus Pharmaceuticals, Inc. · Filed Dec 5, 2023
Insider Transaction Report
Form 4
YARNO WENDY L
Director
Transactions
- Exercise/Conversion
Common Stock
2023-12-02+5,000→ 7,000 total - Exercise/Conversion
Restricted Stock Units
2023-12-02−5,000→ 0 total→ Common Stock (5,000 underlying)
Footnotes (3)
- [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
- [F3]RSUs granted in connection with the Reporting Person's service as the Lead Independent Director. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.